---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-23-000024"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T05:00:30.803134+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics stockholders elect all nine director nominees at 2023 annual meeting

## Summary
- All nine director nominees elected with >98% of votes cast; broker non-votes 10.7M shares.
- Say-on-pay approved with 64.7M For (98.4% of votes cast); frequency set to every three years.
- Ratification of Ernst & Young as auditor for FY2023 passed with 75.6M For (98.8% of votes cast).
- Say-on-pay frequency vote: 63.0M for 3 years, 2.3M for 1 year; company to hold vote every 3 years.

## SEC filing metadata
- accession: 0001641489-23-000024
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/0001641489-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/vtvt-20230606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-23-000024
- JSON: https://secwatch.observer/filing/0001641489-23-000024.json
- Plain text: https://secwatch.observer/filing/0001641489-23-000024.txt

## Key facts
- Shareholder Votes
  vTv Therapeutics Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified based on the following results of the voting: For Against Abstain Broker Non Votes 75,554,888 895,657 37,434 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/0001641489-23-000024-index.htm
- Shareholder Votes
  vTv Therapeutics Inc. shareholders approved Set frequency of future nonbinding advisory votes on executive compensation at every three years at the 2023-06-06 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders set the frequency of future nonbinding advisory votes on the compensation paid to the Company’s named executive officers as every three years based upon the following results of the voting: 1 Year 2 Years 3 Years Abstain Broker Non Votes 2,342,432 114,442 63,036,155 307,105. 10,687,845
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/0001641489-23-000024-index.htm
- Shareholder Votes
  vTv Therapeutics Inc. shareholders approved Election of Directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Based on the following results of the voting, the Company’s stockholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a term to expire at the Company’s 2024 annual meeting of stockholders or until their successors are duly elected and qualified: Director Nominee For Withheld Broker Non Votes John A. Fry 65,554,590 245,544 10,687,845 Chandresh Harjivan 65,530,597 269,537 10,687,845 Keith Harris 65,281,995 518,139 10,687,845 Jonathan Isaacsohn 65,386,409 413,725 10,687,845 Hersh Kozlov 64,477,507 1,322,627 10,687,845 Fahed Al Marzooqi 65,413,332 386,802 10,687,845 Richard S. Nelson 65,280,700 519,434 10,687,845 Paul Sekhri 65,539,487 260,647 10,687,845 Howard L. Weiner 65,392,364 407,770 10,687,845
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/0001641489-23-000024-index.htm
- Shareholder Votes
  vTv Therapeutics Inc. shareholders approved Advisory vote on executive compensation at the 2023-06-06 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders approved on a nonbinding advisory basis the compensation paid to the Company’s named executive officers based upon the following results of the voting: For Against Abstain Broker Non Votes 64,740,672 911,509 147,953 10,687,845
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000024/0001641489-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.